
IRFC IPO Subscription Status
IRFC IPO Subscription Status The Rs 4600 crore IPO is open for subscription during Jan 18- Jan 20 at a price band of Rs 25-Rs 26 per equity share. Investors [Read More…]
IRFC IPO Subscription Status The Rs 4600 crore IPO is open for subscription during Jan 18- Jan 20 at a price band of Rs 25-Rs 26 per equity share. Investors [Read More…]
IRFC IPO Review IRFC IPO Details, Analysis The first IPO of the year 2021 is coming up with IRFC launching its IPO worth Rs 4633 crore on 18th Jan. Look [Read More…]
Gland Pharma has robust business model and strong financial performance since 2017 when Fosun took over major stake; post IPO its stake would come down to 58%. The IPO is worth investing if the geopolitical tension remains subdued. However investors wary of external risk may consider investing based on their risk appetite.
Copyright © 2021 | WordPress Theme by MH Themes